English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & PCEM
CAIVD
PCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
New research identifies potential new targets for the treatment of cancer
2015-04-13
New research at the University of Aberdeen has identified potential new targets for the treatment of certain types of cancer. This research could lead to the development of new drug therapies tailored to individua..
AstraZeneca plc (ADR) And Myriad Genetics, Inc. Expand Collaboration On Lynparza
2015-04-10
Myriad’s BRAC Analysis CDx test will be used to identify prospective patients of metastatic pancreatic cancer who could respond to AstraZeneca’s Lynparza AstraZeneca plc (ADR) (NYSE:AZN) and Myriad Gen..
Rapid Group A Strep Test Clears FDA
2015-04-07
The US Food and Drug Administration (FDA) has approved marketing clearance for the Alere i Strep A test (Alere Inc), the first molecular test that detects group A streptococcus bacteria in throat swab specimens in 8 m..
Sequencing-Based Testing Sector Already Highly Competitive
2015-03-31
As next-generation sequencing (NGS) reaches the clinical laboratory, a new analysis by Kalorama Information (New York, NY, USA) finds that small reference laboratories as well as over 50 companies now offer sequencing..
Diagnostics Rapidly Gain Ground in Infectious Diseases Sector
2015-02-06
According to a new Frost & Sullivan (Mountain View, CA, USA) analysis, convergence of immunological and molecular tests will help meet growing needs for infectious disease (ID) diagnostics. Although these tests re..
Market for qPCR Exceeds USD 3 Billion
2014-11-28
The market for real-time quantitative polymerase chain reaction (qPCR) was valued at about USD 3.2 billion for 2013 according to Kalorama Information (New York, NY, USA) an increase from USD 2.8 billion in 2011. The h..
Blood Sector Continues to Experience Solid Growth
2014-11-28
The global blood industry has experienced strong growth in recent years and growth will remain solid though 2018, according to the new report, "Blood: The Worldwide Market for Blood Products, Blood Testing, Blood..
Health-care pricing in China
2014-10-31
In China, violence against medical staff has drawn worldwide attention, and occurs for many reasons, as discussed previously. As first-line heath-care workers in China, we think the absence of transparency and mar..
EKF and Mass. General Collaborate to Develop Blood Tests for Cancer Patients
2014-10-11
EKF Molecular, of EKF Diagnostics (Cardiff, UK), and Massachusetts General Hospital (MGH; Boston, MA, USA) have entered into a 2-year research collaboration to develop PointMan assays that can effectively detect treat..
Thermo Fisher to develop companion diagnostics for GSK and PFE
2014-10-08
Thermo Fisher Scientific (NYSE: TMO) enters into an agreement with GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) to develop a universal next-generation sequencing (NGS) oncology test for solid tumors that will se..
Emergency Approval of Ebola Test Suggests Opportunity for Test Makers
2014-10-08
The emergency approval of a real-time PCR test for Zaire Ebolavirus demonstrates the scope of concern about the recent epidemic and a possible opportunity for test makers. The biennial study of the microbiology test p..
FDA Clears Rapid Blood Test for Sepsis-Causing Pathogens
2014-09-29
The US Food and Drug Administration (FDA) has cleared for marketing the first direct blood test capable of rapidly detecting 5 Candida species that cause bloodstream infections that often lead to sepsis. The T2Can..
First European Company Obtains CE-IVD Marking for Next Generation Sequencing in Routine Testing
2014-09-29
For the first time, a European company, Sophia Genetics (Lausanne Switzerland), has obtained the CE-IVD mark for clinical use of Next Generation Sequencing (NGS) bioinformatics pipeline for routine genetic testing. ..
Funding Awarded to Develop Diagnostic Point-of-Care Device for Sickle Cell Disease
2014-09-29
Rockland Immunochemicals, Inc. (Limerick, PA, USA) has announced the award of a USD 224,473 Small Business Innovation Research (SBIR) grant from the NIH National Heart Lung and Blood Institute (NHLBI) to develop an an..
Initiative Launched to Make Genetic Profiles a Routine Part of Clinical Decisions
2014-09-29
Laboratory Corporation of America Holdings (LabCorp; Burlington, NC, USA) has launched “Enlighten Health Genomics,” a new business that builds on the diagnostic potential of next-generation sequencing (NGS..
Total:
3024
Pages:
202
First
Prev
1
..
196
197
198
199
200
201
202
Next
End